1
Nomura Y, et al. Clin Drug Invest. 2000;20(5):357-369
2
Grimm SW, et al. Drug Metab Dispos. 1997;25(5):598-602
3
Dowsett M, et al. Eur J Cancer. 1998;34(S1),abs.100,S39-S40
4
小山博記, 他. 乳癌の臨床. 2000;15(5):577-583
5
小山博記, 他. 乳癌の臨床. 2000;15(5):567-576
6
Dowsett M, et al. Cancer Chemother Pharmacol. 2000;46(1):35-39
7
Watanabe T, et al. Proc Am Soc Clin Oncol. 2000;19:abs.396,103a
8
Bonneterre J, et al. J Clin Oncol. 2000;18(22):3748-3757
9
The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Cancer. 2003;98(9):1802-1810
10
The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Lancet. 2005;365(9453):60-62
11
Cataliotti L, et al. Cancer. 2006;106(10):2095-2103
12
Geisler J, et al. Br J Cancer. 1996;74(8):1286-1291
13
Dukes M. Oncology. 1997;54(Suppl.2):6-10
14
Lu Q, et al. Breast Cancer Res Treat. 1999;57(2):183-192
15
Dukes M, et al. J Steroid Biochem Molec Biol. 1996;58(4):439-445